MAPA/MAPS Medical Affairs Summit 2024 - Full Two-Day Summary

Date:?October 30-31, 2024

Location:?ICC Sydney, Australia: https://maps.eventsair.com/aunz2024/register-now

Attendance:?300 Medical Affairs professionals from across the industry

Day One: Wednesday, October 30, 2024

Day One of the MAPA/MAPS Medical Affairs Summit 2024 will commence with a focus on redefining the role of Medical Affairs in a rapidly evolving healthcare environment. The sessions will explore the latest trends in communication strategies, patient engagement, digital transformation, and AI integration, highlighting the critical role of Medical Affairs professionals in driving healthcare innovation.

9:00 AM - 9:15 AM: Welcome and Opening Remarks (TBD) An introduction to the Summit, emphasizing the critical role of Medical Affairs professionals in the evolving healthcare landscape.

9:15 AM - 10:30 AM: Opening Keynote - Adam Spencer renowned science communicator, will deliver an inspiring keynote on data science, communication, and the changing dynamics of the healthcare industry, encouraging attendees to embrace innovation.

10:30 AM - 10:45 AM: Morning Tea Break

10:45 AM - 12:15 PM: Morning Workshops

• From Good to Great: Accelerating the Impact of the Science Through Positive Communication Speakers: Pauline Bernard ?(The Right Outcome), Brigid Waite (Roche), Christina Haskis (AbbVie), Colleen Kavanagh (Resiliens) This workshop will focus on enhancing communication within Medical Affairs, emphasizing trust-building and effective stakeholder engagement.
• Patient Affairs in Action: Moving from Concept to Practice Speakers:? Sara McLaughlin-Barrett (MedWise Consulting), Sam Pearson (Abbvie) and Kyren Lazarus (AZ) will deep dive into the evolution of Patient Affairs and the integration of digital tools to enhance patient-centric strategies.
• Future of Precision Medicine in Oncology: Tissue Agnostic Biomarker-Driven Therapies Speaker:? Alan Watts (AbbVie) A session addressing the scientific and regulatory challenges in tissue-agnostic biomarker-driven oncology therapies. *further speakers tba

12:15 PM - 1:15 PM: Lunch Break

1:15 PM - 2:15 PM: Expanding Horizons: Digital Solutions for Enhancing Patient Engagement and Support in Medical Affairs Speakers:?Amit Lalwani (MAPA), Densearn Seo (Drop Bio Health), Menaka De Alwis (Novartis), Sophie Seck (Medicines Australia) A panel exploring digital innovations in patient engagement, highlighting the role of Medical Affairs in implementing these tools.

2:15 PM - 3:45 PM: Afternoon Workshops

• From Insight to Impact: Rethinking Patient Support Co-Design in the Modern World Speakers: Jane Choi, PhD (Atlantis Health), Dan Mellor (Antengene), Gareth Davidson (Atlantis Health) Focuses on integrating stakeholder voices into patient support design for targeted and effective outcomes.
• Mastering Networking: Accelerating Impact in Medical Affairs Speakers:? Niloufar Ansari (AstraZeneca), Tamara Etto (Antengene), Daniel Thurley (University of Sydney), Maggie Lieu, PhD (Menarini) Practical networking strategies, including AI-driven personalization, to expand professional influence in Medical Affairs.
• Strategic Thinking in Medical Affairs – "How Do You Effectively Manage Large Medical Projects?" Speakers:? Robin England (AstraZeneca), Brigid Waite (Roche), Jodi Tainton (Pfizer), Jon Zdon (Novartis) Equips participants with project management and strategic thinking skills to manage complex medical projects.

3:45 PM - 4:00 PM: Afternoon Tea Break

4:00 PM - 4:30 PM: Do More, With Less: How AI & Smart Content Management are Revolutionizing Medical Affairs Speakers:? Tristan Reid (Ward7), Jon Zdon (Novartis) Exploring how AI and content management systems drive efficiencies in Medical Affairs.

4:30 PM - 5:00 PM: Oh, the Places You’ll Go! How Should Medical Affairs Professionals Engage with Generative AI to Maximize Its Potential Speakers:? Vin Jayewardene, Ph.D. (Daiichi Sankyo), Scott Thomas (CSL Vifor), Huey Wen Lee, PhD (Medwise Consulting), Sinthuja Siva (AbbVie) A session discussing the transformative potential of generative AI, including regulatory challenges and practical AI integration in Medical Affairs.

5:00 PM - 5:05 PM: Day One Close

Day Two: Thursday, October 31, 2024

Day Two will build on the insights from Day One, focusing on evidence generation, digital transformation, and the development of strategic competencies within Medical Affairs.

9:00 AM - 9:15 AM: Opening Remarks

9:15 AM - 10:30 AM: ABC of HEOR and RWE: Raising the Stakes of Evidence Generation and Application in Australasia Speakers: Steven Inglis (Oxford PharmaGenesis), Krishan T. (Pfizer), Anne-Maree Englund (Medicines Australia) Explores the critical role of Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) in driving evidence generation strategies and accelerating patient access.

10:30 AM - 10:45 AM: Morning Tea Break

10:45 AM - 12:15 PM: Thursday Morning Workshops

• Harnessing Digital/AI to Drive Field Medical Excellence Speakers: Maggie Lieu, PhD (Menarini), Jennifer W. (Astellas) Focuses on enhancing Field Medical engagements through digital and AI strategies.
• Field Medical Impact Measurement: Develop Practical Measures for Field Medical Based on the Outcomes of a Global Biopharma Consensus Speakers: Jodi Tainton (Pfizer), Lina Fusco (Pfizer) A session on defining meaningful metrics to measure Field Medical impact.
• Innovative & Sustainable People Development Approaches Speakers: Faizz Fattah (eMBA) (Amgen), Sian Davis (AstraZeneca), Diana Lau (Pharmaverse) Discusses modern mentoring and coaching methods for sustainable talent development in Medical Affairs.

12:15 PM - 1:15 PM: Lunch Break

1:15 PM - 2:15 PM: Plenary (30 mins each)

Panel Discussion: Delivering a MAPA Competency Framework to Strengthen Medical Affairs Excellence Across Australasia Speakers: Orin Chisholm (USYD), Cathey Saha (Abbvie), Krishan T. (Pfizer) and cae tolman (Amgen). This panel discussion will explore how the MAPA Competency Framework enhances Medical Affairs excellence across Australasia by defining essential skills, standards, and professional development pathways for Medical Affairs professionals.

Myth Or Reality, incompatible or ideal: A Panel Discussion on unveiling career paths in Medical Affairs: Speakers Bernd Merkel (Teva), David Henderson (Biogen) Lindsay Grant (Abbvie). Attendees will gain enhanced analytical skills, flexible proficiency, and a career-oriented performance mindset, empowering them to make informed career decisions, tailor personal development plans, and strategically align their skills with long-term leadership roles in Medical Affairs.

2:15 PM - 3:00 PM: Thursday Afternoon Workshops - Best Practice Session 1

• The Critical Role for Medical Affairs Professionals in Integrated Strategy Development for Innovative Therapies Speakers: Tamara Etto (Antengene), Kevin Lynch (Antengene), Dan Mellor (Antengene) Highlights the importance of strategic planning in the development of innovative therapies.
• The Strategic MSL: Integrating Business Acumen and Tactical Thinking Speakers: Snehal Gorey (Pfizer), Soteria Simos (Pfizer), ALVARO SANCHEZ HERRERO (Menarini) Explores how MSLs can enhance their roles by incorporating business acumen and tactical thinking.
• Unlocking Market Access: Innovative Medical Affairs Approach in Australia Speakers: Diana Lau (Pharmaverse), Anita Ackerman (Recordati Rare Disease Australia), Kelly Makarounas-Kirchmann, GAICD (KMC Health Care) Discusses strategies to enhance the role of Medical Affairs in market access.

3:00 PM - 3:15 PM: Afternoon Tea Break

3:15 PM - 4:00 PM: Thursday Afternoon Workshops - Best Practice Session 2

• Redefining the Role of Medical Affairs in the Evolving Technological Landscape Speaker:?. Vidula Damle (Mayne Pharma) Insight into how evolving technologies are reshaping Medical Affairs functions.*
• Future-Ready Teams: Mastering Engagement, Strategic Succession Planning, and Talent Development in Medical Affairs Speakers: Alicia Parkes (AbbVie), Lauren Pasfield (MAPA/AbbVie), Angelle Lockie lock (AbbVie), Aitor Arteaga (AbbVie) Best practices in team development, succession planning, and engagement.
• Get Your Ideas Heard: How to Demonstrate the Value of Your Project in a Cross-Functional Environment Speaker: Philip Murphy (Gilead) Guidance on pitching project ideas effectively and prioritizing initiatives in cross-functional teams.*

4:00 PM - 5:00 PM: Supercharging Drug Development Highways: Public/Private/Industry Partnerships in the Pursuit of Personalized Access to Medicines Across Therapeutic Areas – Moderated by Bevan Sweerts and Matthew Britland

Speakers:?

Deborah Burnett (Group Leader at Garvan Institute of Medical Research; Senior Lecturer at St Vincent’s Clinical School):?Dr. Burnett will delve into the crucial role that academic and research institutions play in vaccine development. Her presentation will explore how collaborative research efforts are advancing our understanding of immune responses, particularly focusing on B cells and immune mechanisms. Dr. Burnett’s research aims to improve vaccine efficacy and safety through deeper insights into how the immune system can be harnessed to protect against infectious diseases.

Gemma Figtree (Interventional Cardiologist, RNSH; University of Sydney; President Australian Cardiovascular Alliance):?Prof. Figtree will discuss the significant impact of public/private partnerships in the cardiovascular field, highlighting how these collaborations are accelerating drug development and clinical breakthroughs. Her research utilizes advanced imaging and molecular techniques to uncover the underlying mechanisms of heart disease, offering potential pathways to enhance therapeutic outcomes and personalize cardiovascular care.

David Thomas (Director Centre for Molecular Oncology, UNSW; Chief Science and Strategy Officer, Omico; Laboratory Head, Genomic Cancer Medicine, Garvan Institute):?Prof. Thomas will provide an overview of the advancements in oncology driven by public and private sector collaborations. He will elaborate on OMICO’s PrOSPeCT program, a groundbreaking initiative that integrates genomic research into personalized cancer treatment. His presentation will highlight how these partnerships are enabling the rapid translation of genomic discoveries into clinical practice, thus driving forward personalized medicine in oncology.

Matt Zeller (Country President, Novartis ANZ):?From an industry perspective, Matt Zeller will discuss the pivotal role of collaboration in developing innovative therapies. He will focus on advancements in Radio-Ligand Therapy (RLT) and Theranostics, demonstrating how these cutting-edge technologies are transforming the oncology landscape. Zeller will underscore the importance of fostering partnerships between industry and research institutions to bring these novel treatments to patients, emphasizing the collaborative efforts needed to overcome regulatory and access barriers.

This session will explore how partnerships between public, private, and industry sectors are driving advancements in drug development and personalized medicine, highlighting successful strategies and future trends that are transforming access to innovative therapies.

5:00 PM - 5:05 PM: Day Two Close

This comprehensive two-day event will empower Medical Affairs professionals to enhance their strategic impact, navigate evolving technologies, and foster partnerships that will shape the future of healthcare.

It was a pleasure to be part of the amazing organising commitee led brilliantly by Jan Lewis .

Jon Liong Debra Bourke Bevan Sweerts Victoria Elegant Marina van der Merwe, PhD Amit Lalwani Lauren Pasfield Jodi Tainton Riaz Abbas

Register now, places are limited to 300: https://maps.eventsair.com/aunz2024/register-now

https://maps.eventsair.com/aunz2024/speaker-list

?